瑞银上调吉利德科学目标价至145美元
Group 1 - UBS raised Gilead Sciences' target price from $112 to $145, indicating a positive outlook for the company [1] - The rating was upgraded from "Neutral" to "Buy," suggesting increased confidence in Gilead's future performance [1]